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Adrenocorticotropic hormone (ACTH) is secreted in response to
a number ofstimuli and it influences growth, differentiation and adrenal
steroidogenesis. Rat pituitary ACTH-cells are differentiated at 14-16
days of fetal life, while synthesis of adrenal glucocorticoids starts from
the 17th day of gestation as a result of increased synthesis and release
of ACTH. The aim of this work was to examine the effect of
dexamethasone (Ox), administered to gravid females, on the synthetic
ability of their pituitary ACTH-cells as well as those of their fetal and
neonatal offspring. The experimental group of pregnant females
received Ox (1.5 mg/kg bW) on day 16 of gestation, while the control
group received an equal volume of diluent at the same time. Plasma
ACTH and cortisol concentrations were determined by RIA. The
ACTH-cells were examined under light and electron microscopes.
Theresults obtained indicate that single Ox-treatment of pregnant
rats suppresses differentiation of fetal adrenocortical cells and the
release of ACTH. However, in neonatal rats the number of ACTH- and
precursor cells and their proliferation increased, as well as ACTH and
cortisol synthesis and release, i. e. stimulation of synthesis and
secretion of ACTH was noticed after suppression in the fetal period.
The numerous changes observed in the fetuses and early
neonates of dams treated with a single dose of Ox during pregnancy
had disappeared in 3D-day-old offspring.
Key words: pituitary, ACTH-cells, fetal period, neonatal period,
adult period, dexamethasone.
INTRODUCTION
Corticotropin-releasing hormone (CRH), a hypothalamic neuropeptide
(41-amino acids), plays the major role in regulating the function of the
hypothalamic-pituitary-adrenocortical axis (HPA). CRH, together with other
neuropeptides and neurotransmitters, stimulates synthesis and release of
adrenocorticotropin (ACTH) from anterior pituitary ACTH-cells.
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CRH and CRH binding sites in the brain and pituitary have been
demonstrated in 16-day-old rat fetuses (Insel et aI., 1988). Pituitary receptors for
CRH, which are present in the prenatal period, are sensitive to glucocorticoid
feedback inhibition at the end of gestation (Brooks et aI., 1989).
Immunocytochemical investigations offetal rat pars distalis have shown that
ACTH-cells are the first cell type which can be identified. ACTH-cells are
differentiated at 14-16 days of fetal life (Setalo and Nakane, 1976, Nemeskeri et
aI., 1989), while synthesis of adrenal glucocorticoids starts from the 17th fetal day
as a result of increased synthesis and release of ACTH (Nemeskeri and Halasz,
1989, Kachaturian et aI., 1983; 1991).
Placental-fetal metabolic interrelationships are very important in the control
and determination of many aspects of fetal development (Hay, 1995). Maternal
corticosteroids can cross the placental barrier to reach the fetuses before delivery,
but fetuses have lower physiological levels of glucocorticoids than their dams
(Kittinger, 1974).
Treatment with dexamethasone (Ox) during ontogenesis induced:
retardation offetal growth (Hristic et aI., 1995, 1997a, Slotkin et aI., 1992), alteration
in the rate of maturation of some organs such as the lung (Seckl and Miller; 1997),
kidney (Wintour et aI., 1994), hypothalamic nuclei PVN, and adrenal atrophy
(Hristic et aI., 1995, 1997a, 1997b). Studies in baboons demonstrated that
placental corticosteroid metabolism dictates the amount of cortisol arriving in the
fetuses and regulates fetal pituitary adrenocortical function (Pepe, 1994).
The aim of this work was to examine the effect of Ox, administered during
gestation as a single dose on day 16 of gestation, on the synthetic activity of
pituitary ACTH-cells of the fetuses and neonatal offspring. In addition, analysis of
ACTH-cell synthetic activity was performed on the dams.
MATERIAL AND METHODS
Treatment of animam
These investigations involved pregnant Wistar strain rats, their male fetuses
(20-day-old) and neonatal offspring (3- 14- and 30-day-old). Three-month-old rats
were mated in the laboratory. The day when females were sperm-positive was
considered as the first day of pregnagcy. Pregnant rats were housed individually
in conditions of controlled heating (22 C) and lighting (12 h light/dark cycle). Food
and water were offered ad libitum. On day 16 of gestation pregnant females were
housed indiVidually and divided into two groups: experimental and control.
Experimental procedure
The experimental group received Ox (Krka, Novo Mesto, Slovenia) ip (1.5
mg/mg/kg bw) on day 16 of gestation, while the control group received an equal
volume of diluent at the same time. Fetuses (20-day-old) and neonatal offspring
(3-, "14- and 30-day-old males) from both control and experimental rats were
divided into 3 subgroups consisting of 5-10 animals. Their blood was used for
measurement of ACTH and cortisol concentrations (subgroups I and II), and their
pituitary glands for light and electron microscopy (subgroups III). Plasma ACTH
concentration was also determined in experimental and control dams 3, 14 and
30 days after delivery (subgroup IV). All rats in the study were sacrificed by
decapitation under light ether narcosis between 9h and 11 h.
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Plasma ACTH determination
After killing the animals, trunkePlood was collected and, after separation,
plasma was frozen and kept at -20 C. Plasma concentrations of ACTH were
determined by radioimmunoassay (RIA). The blood collected from six fetuses or
3-day-old neonatal rats was pooled and considered as one sample. Blood
samples from 14- and 30-day-old offspring were examined individually.
Plasma cortisol determination
Cortisol concentrations were determined using a commercial RIA kit
(Cortisol-RIA kit. INEP, Zemun).
Electron microscopy
The pituitary glands were removed quickly and 1mm3 slices were fixed in
3% glutaraldehyde buffered to 7.2 with 0.1 M phosphate. Tissue was postfixed in
1% osmium tetraoxide in 0.1 M phosphate buffer (7.2), dehydrated in a graded
series of acetone and embedded in araldite. Semithin and thin sections were cut
with glass knives on an LKB ultramicrotome IIIand stained with toluidine blue-azur
II and methylene blue or uranylacetate and lead citrate, respectively.
Statistical analysis
Data were expressed as group means ±SD. The difference between two
means was evaluated by Student's t-test and between three means by one-way
analysis of variance followed by the least significant difference test (LSD).
RESULTS
Concentration of ACTH in the plasma
In fetuses and offspring of the control females, the values for plasma ACTH
concentration were approximately the same in all four tested periods (Table 1.).
Table 1. Plasma ACTH concentration (pmol/L) in fetuses (20-day-old) and
offspring (3-, 14- and 3O-day-old) of dams injected with saline (C) or
dexamethasone (Dx) (1.5 mg/kg bw) on day 16 of gestation.
20-day-old 3-day-old 14-day-old 3O-day-old
fetuses neonates neonates rats
C 40.81 ± 5.47 38.97 ± 3.67 42.39 ± 2.83 43.33 ± 2.55
Ox 35.23 ± 3.99 55.38 ±3.370 a 58.97 ±3.08** a 40.45 ± 2.52
Results are expressed as mean ±SD for 5 samples in each group.
*p< 0.01 and **p< 0.005 vs C
ap< 0.01 vs 20-day-old fetuses
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The mean plasma concentration of ACTH in 3- and 14-day-old offspring of
Ox-treated dams was markedly increased compared with fetal values (3-day-old
rats vs. fetuses - 57%; 14-day-old rats vs. fetuses - 67%) and compared with control
values for the same period. Thus, in 3- and 14-day-old pups from Ox-treated dams
ACTH concentration in plasma was significantly increased by 42% and 39%,
respectively (Table 1.).
Moreover, the mean value for ACTH concentration was higher on the 3rd
day after delivery in Ox-treated dams than in control dams (58%) (Table 2.). In the
control dams, a significant decrease in plasma ACTH concentration was observed
in the period from 3 to 30 days after delivery (14 day vs. 3 day - 24%; 30 day vs.
3 day - 36%). In Ox-treated dams this decrease in plasma ACTH concentrations
was more marked (14 day vs. 3 day - 60% and 30 day vs. 3 day - 51%).
Table 2. Plasma ACTH concentration (pmol/L) in dams injected with saline (C)
or dexamethasone (Dx) (1.5 mg/kg bw) on day 16 of gestation.
Days after delivery
3 14 30
,
C .69.30 + 4.64 52.33 + 5.17 a 44.62 + 5.70 b
Dx 102.49 ± 10.83 * 41.17 + 3.20 c 50.34 + 3.11 c
Results are expressed as mean ± SD for 5 animals in each group
*p< 0.025 vs C
ap< 0.05 vs dams 3 days after delivery
bp< 0.01 vs dams 3 days after delivery
cp< 0.01 vs dams 3 days after delivery
Cortisol concentration in plasma
In the 14-day-old offspring from control dams plasma cortisol concentration
was greatly increased compared to 3-day-old pups (14-day-old vs. 3-day-old -
77%). In 3·· and 14-day-old pups from Ox-treated dams the values of plasma
cortisol concentration were much higher than in 30-day-old offspring (63% and
62%, respectively). Mean plasma concentration of cortisol in 3-day-old neonates
of Ox-treated dams was about 2.5 fold higher than in the corresponding controls
(Table 3.).
ACTH-cells.
Adrenocorticotrophic-celis of the anterior pituitary gland of perinatal control
rats were usually irregular in shape and localized among the somatotropin and
prolactin-cells. Secretory granules of ACTH-cells (diameter 120-200nm) were
distributed mainly near the plasma membrane. Some of them, near the Golgi
apparatus appeared solid and some had central cores. The mitochondria,
endoplasmatic reticulum and Golgi apparatus were localized near the nucleus.
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Table 3. Plasma cortisol concentration (nmol/t) in offspring (3-, 14-- and 30-
day-old) of dams injected with saline (C) or dexamethasone (Ox) (1.5
mg/kg. bw) on day 16 of gestation.
3-day-old 14--day-old 3O-day-old
neonates neonates rats
C 12.09 ± 0.98 21.40 ± 3.42 a 12.94 ± 1.18 b
Dx 30.64 ± 1.58* 29.69 ± 4.52 c 11.40 ± 1.22 c d
Results are eXpressed as mean ± SO for 5 samples in the group.
*p < 0.01 vs C
ap < 0.05 vs 3-day-old pups
bp < 0.05 vs 14-day-old pups
"P < 0.01 vs 3-day-old pups
dp < 0.01 vs 14-day-old pups
In ACTH-cells of fetuses from Dx-treated dams, an increased number of
secretory granules was noted in the region of the Golgi apparatus. In 3- and
14-day-old neonatal pups the secretory granules were localized near the plasma
membrane, and their formation in the Golgi apparatus was observed (Fig. 1.). In
addition, an increase number of mitoses in precursor cells was found (Fig. 1).
Figure 1. Electron microscopy of ACTH-cell of 14-day-old pup from Ox-treated dam. The secretory
granules are localized in the vicinity of the plasma membrane. The Golgi apparatus is well
developed and numerous mitochondria are present. (Bar 111m).
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Figure 2. Electron microscopy of precursor cells of 3-day-old offspring of Ox-treated dams. A.
Precursor cell in the process of mitosis. (Bar 1urn).
There were no differences in structure of ACTH-cells between 30-day-old
offspring from Dx-treated dams and the corresponding controls (Fig. 2, A)
ACTH-cells of experimental dams, 3 days after delivery were almost without
secretory granules but with hypertrophic nuclei. However, 30 days after delivery
such alterations in the structure of these cells were not seen (Fig. 3A, B).
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Figure 3. ACTH-cells of an experimental dam (semithin sections, stained with toluidine blue-azur II
and methylene blue). A. 3 days after delivery with hypertrophied nuclei and with scarce
secretory granules. B. ACTH-cell of experimental dam 30 days after delivery.
DISCUSSION
The results of this study demonstrate that a single dose of Ox, given to
pregnant rats on day 16 of gestation, changed the synthetic activity of ACTH-cells
in the anterior lobe of the pituitary gland of the dams and their offspring.
Our previous examinations showed that a single maternal Ox-treatment (1 .5
mg/kg bw) led to a significant decrease in body and adrenal weight of the fetal
and neonatal offspring, and also to a reduction of cortical cell number due to
decreased cell proliferation (Hristi6 et aI., 1997a, Manojlovi6 et al., 1998, Kalafati6
et al., 1996, 1998). Maternal or fetal stress stimulates placental secretion of CRH
which might have stimulated the fetal HPA axis to secrete glucocorticoids. This
increases the level of glucocorticoids in plasma and reduces average birth weight
(Seckl, 1994). Concerning prenatal alterations in glucocorticoid level, the single
dose of Ox given to pregnant rats in our experiments affected different
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subpopulations of PVN neurosecretory cells indicating changes in the synthesis
of several peptides and/or neurotransmitters. These results confirm and extend
the data concerning the dependence of brain development on prenatal levels of
glucocorticoids (Kalatatic et aI., 1998, Hristic et aI., 1997b). Clinical experience
suggests that there are no teratogenic changes in children of mothers treated with
pharmacological doses of prednisone during pregnancy, but low birth weight of
babies may occur (Lockshin and Sammartano, 1998).
The results of this work show that plasma ACTH concentrations were
approximately equal in fetuses and neonates of control females in all four tested
periods. The hypothalamic CRH mRNA levels did not change significantly during
the period from day 20 of fetal life to the day 15 of postnatal life (Emanuel et aI.,
1989). The fetal ACTH concentration in the experimental group was lower (14%),
but the difference was not statistically significant in comparison with control values.
However, plasma ACTH concentration was significantly increased in neonatal
pups (3- and 14-day-old) of dams treated with Ox (40% and 45%, respectively).
These results indicate that ACTH release, during the early neonatal period, is
increased, i.e. stimulation of secretion of ACTH occurs after suppression in the
fetal period. The differences in ACTH concentration disappeared in 30-day-old
offspring.
In the experiment in which the dose of 1.5 mg/kg bw was divided into five
consecutive doses of 0.3 mg/kg bw given from fetal days 16-20 i.e. in the period
of development of the hypothalamo-pituitary-adrenal system, a significant
reduction in ACTH concentration in the plasma of fetuses and neonatal offspring
was found (Kalafatic et aI., in press). This prolonged treatment with Ox caused
changes in the hypothalamic paraventricular nuclei and adrenal gland that were
of appreciably greater intensity than the changes induced by 1.5 mg Ox given as
a single dose (Hristic et aI., 1997a, 1997b). Ox-treatment decreased the level of
CRH in the paraventricular nuclei (PVN) and median eminence of rats (Jessop et
aI., 1990). Dexamethasone treatment of pregnant rhesus monkeys during late
gestation also evoked a marked decrease of fetal plasma cortisol levels (Challis
et aI., 1974, Walsh et aI., 1979).
The present study also demonstrates that an increase of ACTH
concentration in experimental neonatal pups is followed by markedly increased
plasma cortisol concentrations in the early neonatal period compared with
30-day-old offspring (3-day-old vs. 30-day-old - 63%; 14-day-old Vs 30-day-old -
62%). Previous examinations showed that repeated maternal dexamethasone
treatment caused the opposite change. Namely, a significant decrease of plasma
cortisol concentration in fetuses and 3- and 14-day-old offspring was recorded in
comparison with corresponding controls (Kalatatic et aI., in press).
Electron microscopical analysis of ACTH- and precursor cells are in
agreement with the results obtained for plasma ACTH concentration. An increased
number of secretory granules in the Golgi apparatus and their localization near
the plasma membrane in neonatal pups of experimental dams point to elevated
pituitary ACTH secretion. Membrane binding sites for glucocorticoid have been
found on pituitary cells (Koch et aI., 1978, Sakly and Koch, 1981). Glucocorticoids
are involved in the autoregulation of glucocorticoid receptors (Okret et aI., 1986).
It has also been suggested that glucocorticoid receptors which bind
dexamethasone are localized in the rat brain (Meaney et aI., 1985) and
Ox-treatment induces changes in the level of tissue-specific glucocorticoid
receptors mRNA in the brain of 14-day-old rats (Kalinyak et aI., 1989).
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Analysis of ACTH concentration in the plasma of control and experimental
darns showed that the increase in ACTH 3 days after delivery was more expressed
in Ox-treated dams than in corresponding controls. Thus, we can suppose that,
as a result of Ox-treatment, ACTH is increased after suppression in late gestation.
The ultrastructure of ACTH-cells in the same period, also confirms our hypothesis.
In nonpregnant mammals, ACTH is synthesized predominantly by anterior
pituitary ACTH-cells and regulates glucocorticoid synthesis in the adrenal cortex.
Ouring pregnancy ACTH was found in both the fetal and maternal circulation (Carr
et ai., 1981). ACTH, which is detectable in the fetal circulation, may originate from
fetal pituitary ACTH-cells or from the syncytiotrophoblast cells of the placenta
(Chen et al., 1986, AI-Timini and Fox, 1986). ACTH from the fetal pituitary regulates
primarily the development of human fetal adrenals (Mesiano and Jaffe, 1997).
Maternal glucocorticoids cross the placental barrier in late pregnancy (Kittinger,
1974). The protective placental enzyme 1113-hydroxysteroid dehydrogenase type
2 (11I3HS02) regulates fetal exposure to maternal glucocorticoids, catalyzing
rapid metabolism of cortisol and/or corticosterone to inert 11-keto forms. The
synthetic steroid, dexamethasone, which is a poor sub/strate for 11 r3 HS02, readily
crosses the feto-placntal barrier, and causes much greater effects on the fetal HPA
system than natural glucocorticoids (Seckl, 1997).
Glucocorticoids, given to pregnant rats, suppressed the synthetic activity of
fetal pituitary ACTH-cells, but in the early neonatal period this suppression was
followed by stimulation of ACTH secretion.
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EFEKAT DEKSAMETAZONSKOG TRETMANA GRAVIDNIH ZENKI PACOVA NA MATERNALNE,
FETALNE I NEONATALNE ACTH-CELIJE
DOBRILA KALAFATIC, MIRJANA HRISTIC, BOSILJKA PLECAS I MILICA MANOJLOVIC
-STOJANOSKI
SADRZAJ
Adrenokortikotropni hormon (ACTH) se oslobada kao odgovor na brojne
stimuluse i utica na rast, diferencijaciju i sintezu steroidnih hormona adrenalne
zlezde, ACTH celije u hipofizi pacova diferenciraju se izmedu 14, i 16. dana
fetalnog zivota, dok sinteza glukokortikoidnih hormona nadbubrezne zlezde
pocinje 17. fetalnog dana kao rezultat povecane sinteze i oslobadanja ACTH. Cilj
ovoga rada je bio da se ispita efekat deksametazonskog (Ox) tretmana gravidnih
zenki na ACTH celije fetusa i potomaka tokom neonatalnog perioda. Paralelno je
ispitivana i sintetska aktivnost ACTH celija majki. Eksperimentalna grupa gravidnih
zenki tretirana je Ox (1.5 mg/kg/tt) 16. dana gestac~e, dok je kontrolna grupa u
istom periodu primila odqovarajucu kolicinu fizioloskog rastvora. Koncentracija
ACTH u plazmi odredenaje RIA metodom. ACTH celije fetusa, neonatalnih pacova
i gravidnih zenki ispitivane su svetlosnom i elektronskom mikroskopijom. Rezultati
ovog istrazivanja ukazuju da jednokratni Ox tretman gravidnih zenki inhibitorno
utice na diferencijaciju ACTH celija hipofize fetusa i oslobadanje ACTH. Medutim,
u neonatalnom periodu broj prekursorskih ACTH celija i njihova proliferacija su
povecani, kao i sinteza i oslobadanje ACTH i kortizola, tj nakon perioda inhibicije
u fetalnom dobu dolazi do stimulacije u pogledu sinteze i sekrecija ACTH celija
tokom neonatalnog perioda. Brojne promene opisane tokom fetalnog i
neonatalnog perioda kod potomaka majki jednokratno tretiranih Ox 16. dana
gestacije iscezavaju kod potomaka starih mesec dana.
